Finance

Lists
Portfolios
Track your investments in one place, get AI insights, and more
Top movers in your lists
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXY
Discretionary
SIXY
Discretionary
SIXY
+3.29%
2,346.14
+74.72
+3.29%
2,271.422,330.812,352.792,324.17
SIXB
Materials
SIXB
Materials
SIXB
-2.44%
1,070.98
-26.75
-2.44%
1,097.731,087.301,087.301,066.86
SIXC
Communications
SIXC
Communications
SIXC
+1.51%
565.26
+8.39
+1.51%
556.87556.87566.21556.87
SIXE
Energy
SIXE
Energy
SIXE
+0.99%
1,253.32
+12.24
+0.99%
1,241.081,237.971,256.381,228.10
SIXI
Industrials
SIXI
Industrials
SIXI
+0.79%
1,812.23
+14.18
+0.79%
1,798.051,802.271,819.991,793.87
US market summary
U.S. crude and international benchmark Brent oil futures tumbled roughly 5% to 6% following announcements that new diplomatic talks with Iran will begin. Concerns over the continuous closure of the critical Strait of Hormuz lightened as the executive branch halted planned military strikes, choosing to prioritize a negotiated settlement over nuclear ambitions instead.
Dive deeper with AI
Joint Currency Intervention Weakens the Dollar Against the Yen
The U.S. and Japanese governments officially confirmed a joint intervention in foreign exchange markets to stabilize the Japanese yen, which recently hit historical 40-year lows. This rare coordinated action forced the greenback down to around 155-156 yen, pulling it back from recent peaks that surpassed 163 yen last week.
Dive deeper with AI
Equity Futures Climb Ahead of Key Earnings and Payroll Data
U.S. stock futures experienced a solid rally to kick off the first trading week of August as macro-driven anxieties eased. Wall Street is preparing for a highly anticipated July corporate jobs report alongside an active roster of corporate earnings, including high-profile updates from firms like SpaceX.
Dive deeper with AI
Pharmaceutical Giants Hold Consolidation Talks on Historical Megadeal
European pharmaceutical powerhouse AstraZeneca has reportedly engaged in preliminary merger discussions with its American competitor Bristol Myers Squibb. If finalized, the transaction would represent one of the most substantial corporate tie-ups in corporate history, establishing a combined pharmaceutical titan worth roughly $400 billion.
Dive deeper with AI
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps